$V Headlines Will 2015 be Apple’s blue-chip debut?

New Post Public Reply Private Reply Replies (0) Message Board

Dec 19, 2014 at 10:17 AM

$V Headlines

Will 2015 be Apple’s blue-chip debut? 5:16 p.m. Dec. 15, 2014 - Jennifer Booton
Don't blame oil, Exxon or Chevron for Dow's 200-point drop 1:12 p.m. Dec. 12, 2014 - Tomi Kilgore
Lending Club’s IPO playbook is worth borrowing 6:01 a.m. Dec. 10, 2014 - Ryan Caldbeck
Visa, Goldman Sachs powering Dow to 18,000 4:29 p.m. Dec. 5, 2014 - Tomi Kilgore
Dow marches closer to 18,000 9:00 a.m. Dec. 5, 2014 - Tomi Kilgore
Will Santa come to Broad and Wall? 1:54 p.m. Dec. 1, 2014 - The Trading Deck
The NFL should be stuffing more football into Thanksgiving 10:56 a.m. Nov. 26, 2014 - Jason Notte
Dow buy signals push index higher 11:39 a.m. Nov. 24, 2014 - The Trading Deck
How Obama’s plan on immigration will enrich Wal-Mart 6:15 a.m. Nov. 20, 2014 - Diana Furchtgott-Roth
More of us are using our phones as credit cards 8:17 a.m. Nov. 19, 2014 - MarketWatch
Buffett boosts stakes in Charter, DirecTV, GM and Visa 6:02 p.m. Nov. 14, 2014 - MarketWatch
Is a premium credit card worth it? 4:10 p.m. Nov. 10, 2014 - AnnaMaria Andriotis
Is the DJIA undervalued? 12:45 p.m. Nov. 7, 2014 - The Trading Deck
Why you’re going to pay football prices to watch hockey this year 10:27 a.m. Nov. 7, 2014 - Jason Notte
This stock market rally is for suckers 8:05 a.m. Nov. 5, 2014 - Michael Sincere
In Apple Pay breakthrough, everybody wins 1:44 p.m. Nov. 4, 2014 - David Weidner
Apple Pay isn’t ready to replace your wallet 5:01 a.m. Nov. 4, 2014 - Steve Shear
Starbucks shares slump after hours, GoPro’s rise 6:09 p.m. Oct. 30, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 30, 2014 - MarketWatch
Dow rings up eighth triple-digit gain in October 4:59 p.m. Oct. 30, 2014 - Barbara Kollmeyer

Visa's Sturdy Capital Signals Growth, Regulations a Risk - Analyst Blog 6:09 p.m. Dec. 18, 2014 - Zacks.com
Dow Jones (DJIA) Today: Visa (V) Leads The Day Higher 4:30 p.m. Dec. 18, 2014 - TheStreet.com
It's New! It's Nifty! It's The Dividend Growth 50! 9:19 p.m. Dec. 17, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: 3M (MMM) Leads The Day Higher, Visa (V) Lags 4:30 p.m. Dec. 17, 2014 - TheStreet.com
Ready to Follow Ray Dalio on this Stock 2:07 p.m. Dec. 17, 2014 - GuruFocus.com
Credit Cards, Airlines, Telecom Could Gain In Cuba 11:54 a.m. Dec. 17, 2014 - Investors Business Daily
Graham's Stock Selection Criteria Revisited 8:52 a.m. Dec. 16, 2014 - Seeking Alpha
Sell These 3 Naked Puts in a Volatile Market 4:21 a.m. Dec. 16, 2014 - InvestorPlace.com
Dow Jones (DJIA) Today: Visa (V) Lags 4:30 p.m. Dec. 15, 2014 - TheStreet.com
Buffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015 9:27 a.m. Dec. 15, 2014 - TheStreet.com
Visa Inc. (V): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Dec. 15, 2014 - Zacks.com
An Independent PayPal Must Fend Off Apple, Alipay 4:59 p.m. Dec. 12, 2014 - Investors Business Daily
Lending Club Rises in Debut 6:36 p.m. Dec. 11, 2014 - The Wall Street Journal Interactive Edition
Dividend Growth Investment: Visa And Mastercard 5:26 p.m. Dec. 11, 2014 - Seeking Alpha
Visa Garners A Very Attractive Economic Castle Rating 4:25 p.m. Dec. 11, 2014 - Seeking Alpha
Apple Pay Paves the Way for Long-Term Gains at VeriFone 4:08 p.m. Dec. 11, 2014 - TheStreet.com
The 4 Stocks That Dominated Thursday’s Market 3:24 p.m. Dec. 11, 2014 - 247WallSt.com
10 Best Reasons to Buy (or Receive) an iPhone 6 This Holiday 1:08 p.m. Dec. 11, 2014 - TheStreet.com
2014 Tech Predictions: A Look Back at What Went Right and What Went Wrong 8:58 a.m. Dec. 11, 2014 - TheStreet.com
Lending Club IPO: Finance Business Gets Tech-Stock Allure 6:09 p.m. Dec. 10, 2014 - The Wall Street Journal Interactive Edition

Paramount Group, Inc. Signs Two Leases Totaling 35,500 Square Feet at Liberty Place 8:57 a.m. Dec. 11, 2014 - BusinessWire - BZX
FIDO 1.0 Specifications Are Published and Final - Preparing for Broad Industry Adoption of Strong Authentication in 2015 7:59 a.m. Dec. 9, 2014 - Marketwired
Recent CyberSecurity & Data Breaches Lead to Increased Popularity for Digital Wallets Designed to Combat Credit Card Fraud 8:15 a.m. Dec. 2, 2014 - PR Newswire - PRF
Critical Alerts For DISH Network, Lowes, Nuance Communications, Mylan and Visa Released By InvestorsObserver 9:31 a.m. Nov. 20, 2014 - PR Newswire - PRF
Data Processing and Outsourced Services Equities Technical Analysis - Western Union, MasterCard, Visa, Fiserv, and Global Payments 9:05 a.m. Nov. 13, 2014 - PR Newswire - PRF
Veterans Financial Coalition Welcomes Three New Organizations 11:43 a.m. Nov. 12, 2014 - PR Newswire - PRF
Upcoming Investor Conferences, Survey Results, Corporate Statement, and Third Quarter Results - Research Reports on Visa, Simon, Goldman Sachs, ARCP and Umpqua 9:20 a.m. Nov. 7, 2014 - PR Newswire - PRF
Vendini Joins PCI Security Standards Council to Improve Payment Data Security Worldwide, Hires Former PG&E Security Lead to Innovate Security Techniques 12:10 p.m. Nov. 6, 2014 - Marketwired
Visa Announces Strategic Community Partners for a “Healthy & Vibrant” San Francisco 12:00 p.m. Nov. 6, 2014 - BusinessWire - BZX
NXT-ID Joins FIDO Alliance as a Sponsor Member 8:02 a.m. Nov. 5, 2014 - Marketwired
Visa Inc. to Participate in Upcoming Investor Conferences 8:30 a.m. Nov. 4, 2014 - BusinessWire - BZX
Visa Selects Bangalore as Site for New Technology Center 9:00 p.m. Nov. 2, 2014 - BusinessWire - BZX
Conference Participation, Dividend, Upcoming Annual Meeting, Training Program, and Promotional Event - Research Reports on Santander Brasil, Goldman Sachs, Visa, Banco Santander and American Express 8:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Visa Inc. Announces Record Date for the 2015 Annual Meeting of Stockholders and Declares Quarterly Dividend, Increases Dividend Rate by 20% 4:06 p.m. Oct. 22, 2014 - BusinessWire - BZX
Google Launches Security Key, World's First Deployment of Fast Identity Online Universal Second Factor (FIDO U2F) Authentication 9:07 a.m. Oct. 21, 2014 - Marketwired
Quarterly Earnings Review and New Service Launch - Research Reports on Goldman Sachs, Visa, American Express, Blackstone and Fifth Third Bancorp 8:45 a.m. Oct. 21, 2014 - PR Newswire - PRF
InvestorsObserver releases comments on Amazon, Visa, Yahoo!, Discover Financial, and Chipotle Mexican Grill 9:31 a.m. Oct. 20, 2014 - PR Newswire - PRF
Visa Kicks Off U.S. Chip Card Education for Consumers and Merchants 8:30 a.m. Oct. 17, 2014 - BusinessWire - BZX
Global Acceptance for Latest Mobile Payment Technology Continues to Grow as Biometrics Sector Explodes for Multi-Billion Dollar Digital Payment Industry 8:15 a.m. Oct. 17, 2014 - PR Newswire - PRF
Nearly Half of U.S. Merchant Terminals to Accept Chip in 2015 8:01 a.m. Oct. 17, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

LG's ASIL D Certification: A Game Changer in Autos

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...